Clark Capital Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-296
| Closed | -$311K | – | 448 |
|
|
2024
Q3 | $311K | Buy |
296
+31
| +12% | +$32.6K | ﹤0.01% | 360 |
|
|
2024
Q2 | $279K | Buy |
+265
| New | +$279K | ﹤0.01% | 355 |
|
|
2021
Q1 | – | Sell |
-41,521
| Closed | -$20.1M | – | 363 |
|
|
2020
Q4 | $20.1M | Buy |
41,521
+9,711
| +31% | +$4.69M | 0.33% | 130 |
|
|
2020
Q3 | $17.8M | Sell |
31,810
-18,049
| -36% | -$10.1M | 0.34% | 130 |
|
|
2020
Q2 | $31.1M | Buy |
49,859
+10,311
| +26% | +$6.43M | 0.58% | 46 |
|
|
2020
Q1 | $19.3M | Buy |
+39,548
| New | +$19.3M | 0.49% | 72 |
|
|
2017
Q3 | – | Sell |
-16,089
| Closed | -$7.9M | – | 323 |
|
|
2017
Q2 | $7.9M | Buy |
16,089
+11
| +0.1% | +$5.4K | 0.31% | 97 |
|
|
2017
Q1 | $6.23M | Buy |
+16,078
| New | +$6.23M | 0.28% | 106 |
|